US5965379A
(en)
*
|
1991-07-19 |
1999-10-12 |
Cytimmune Sciences Inc. |
Method for measuring endogenous cytokines
|
GB9309966D0
(en)
*
|
1993-05-14 |
1993-06-30 |
Nordion Int Inc |
Detection of prostrate-specific antigen in breast tumors
|
GB9314623D0
(en)
*
|
1993-07-14 |
1993-08-25 |
Nordion Int Inc |
Localization and therapy with agents directed against prostate specific antigen in breast cancer
|
EP0635575A1
(de)
|
1993-07-22 |
1995-01-25 |
Wallac Oy |
Monoklonale Antikörper gegen Epitope in freiem uber nicht in Alpha-1-antichymotrypsin komplexiertem Prostata spezifisches Antigen
|
EP0652014A1
(de)
*
|
1993-11-10 |
1995-05-10 |
National Institute Of Immunology |
Behandlung von Prostatahypertrophie
|
US5599677A
(en)
*
|
1993-12-29 |
1997-02-04 |
Abbott Laboratories |
Immunoassays for prostate specific antigen
|
US6143864A
(en)
*
|
1994-06-28 |
2000-11-07 |
Merck & Co., Inc. |
Peptides
|
US5866679A
(en)
*
|
1994-06-28 |
1999-02-02 |
Merck & Co., Inc. |
Peptides
|
US5599686A
(en)
*
|
1994-06-28 |
1997-02-04 |
Merck & Co., Inc. |
Peptides
|
GB9415489D0
(en)
*
|
1994-08-01 |
1994-09-21 |
Nordion Int Inc |
Detection of prostate-specific antigen in amniotic fluid
|
EP0725139A3
(de)
*
|
1995-02-03 |
1997-11-26 |
Bayer Corporation |
Rekombinantes prostat-spezifisches Antigen und seiner Verwendung als Immunoassay-Kalibrator
|
US5698402A
(en)
*
|
1995-02-23 |
1997-12-16 |
Dianon Systems, Inc. |
Methods for diagnosing benign prostatic hyperplasia
|
US5614372A
(en)
*
|
1995-02-24 |
1997-03-25 |
Lilja; Hans |
Early detection of prostate cancer (CAP) by employing prostate specific antigen (PSA) and human glandular kallikrein (hGK-1)
|
US5654161A
(en)
*
|
1995-05-12 |
1997-08-05 |
Chiron Diagnostics Corporation |
Method for diagnosing prostate cancer
|
US5807978A
(en)
*
|
1995-06-07 |
1998-09-15 |
Kokolus; William J. |
Immunogenic peptides of prostate specific antigen
|
CA2229427A1
(en)
*
|
1995-09-12 |
1997-03-20 |
The General Hospital Corporation |
Method for early detection of ovarian cancer
|
US5800347A
(en)
*
|
1995-11-03 |
1998-09-01 |
The General Hospital Corporation |
ROC method for early detection of disease
|
US5710007A
(en)
*
|
1995-09-29 |
1998-01-20 |
Luderer; Albert A. |
Methods for diagnosing prostatic adenocarcinoma
|
EP0855910A4
(de)
*
|
1995-10-18 |
2000-07-05 |
Merck & Co Inc |
Verwendbare konjugate zur behandlung der gutartigen prostatehyperplasie
|
EP0789032A2
(de)
*
|
1996-02-01 |
1997-08-13 |
Bayer Corporation |
Verfahren zur Herstellung eines monoklonalen Antikörpers, der zu einer equimolären Responz gegen eine freie und komplexierte Analyseprobe in einem monoklonalen/polyklonalen Sandwichimmuntest
|
US6143509A
(en)
*
|
1996-02-06 |
2000-11-07 |
Abbott Laboratories |
Prostate specific antigen peptides and uses thereof
|
US6037138A
(en)
*
|
1996-04-26 |
2000-03-14 |
The Children's Medical Center Corp. |
Enzyme screen for breast cancer
|
AU775537B2
(en)
*
|
1996-04-26 |
2004-08-05 |
Children's Medical Center Corporation |
Non-invasive enzyme screen for tissue remodelling-associated conditions
|
US6811995B1
(en)
|
1996-04-26 |
2004-11-02 |
Children's Medical Center Corporation |
Non-invasive enzyme screen for cancer
|
WO1998010292A1
(en)
*
|
1996-09-06 |
1998-03-12 |
Centocor, Inc. |
Monoclonal antibodies specific for prostate specific antigen and methods of detecting prostate specific antigen
|
DE19641560A1
(de)
|
1996-10-09 |
1998-04-16 |
Boehringer Mannheim Gmbh |
Monoklonale Antikörper gegen einen Komplex aus humanem ACT und einer Serinprotease
|
US6177404B1
(en)
|
1996-10-15 |
2001-01-23 |
Merck & Co., Inc. |
Conjugates useful in the treatment of benign prostatic hyperplasia
|
US6107103A
(en)
*
|
1996-10-15 |
2000-08-22 |
Procyon Bropharma Inc. |
Assay for PSP94 protein
|
IL121659A
(en)
*
|
1996-10-25 |
2000-07-16 |
Bayer Ag |
Method for determining CPSA in a blood sample
|
US5840501A
(en)
*
|
1996-10-25 |
1998-11-24 |
Bayer Corporation |
Determination of cPSA
|
US5856182A
(en)
*
|
1996-11-18 |
1999-01-05 |
Beckman Coulter, Inc. |
Monoclonal antibodies specific for the PSA-ACT complex
|
US6548260B1
(en)
*
|
1997-01-21 |
2003-04-15 |
Bayer Corporation |
Detection of PSA-α2-macroglobulin complex in a biological fluid
|
US6309816B1
(en)
*
|
1997-04-16 |
2001-10-30 |
Horus Therapeutics, Inc. |
Methods for diagnosing cancer by measuring creatine kinase
|
DE19717436C2
(de)
*
|
1997-04-25 |
2001-02-15 |
Biomac Gmbh |
Verfahren zur exakten Bestimmung von Prostata-spezifischem Antigen in Körperflüssigkeiten
|
US7288636B2
(en)
*
|
1997-04-30 |
2007-10-30 |
Hybritech Incorporated |
Forms of prostate specific antigens and methods for their detection
|
EP0983509B1
(de)
*
|
1997-05-14 |
2005-08-17 |
Biosite Diagnostics Inc. |
Schnelle bestimmung des verhältnisses von biologischen molekülen
|
US6649420B1
(en)
*
|
1997-08-26 |
2003-11-18 |
Thomas L. Cantor |
Methods and devices for detecting no-complexed prostate specific I antigen
|
US5994085A
(en)
*
|
1997-08-26 |
1999-11-30 |
Cantor; Thomas L. |
Methods and devices for detecting non-complexed prostate specific antigen
|
US6300088B1
(en)
|
1997-11-24 |
2001-10-09 |
Duke University |
Method of detecting prostate specific antigen
|
DE19814915A1
(de)
*
|
1998-04-03 |
1999-10-07 |
Roche Diagnostics Gmbh |
Immunologisches Verfahren zur Bestimmung von PSA
|
FI981185A
(fi)
*
|
1998-05-28 |
1999-11-29 |
Stenman Ulf Haakan |
Uusi diagnostinen menetelmä
|
FI981186A
(fi)
*
|
1998-05-28 |
1999-11-29 |
Stenman Ulf Haakan |
Uusi immunomääritys ja sen käyttö diagnostiikassa
|
AU5128799A
(en)
*
|
1998-07-24 |
2000-02-14 |
Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The |
Pb 39, a gene dysregulated in prostate cancer, and uses thereof
|
US7226731B1
(en)
|
1998-07-24 |
2007-06-05 |
The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services |
PB 39, a gene dysregulated in prostate cancer, and uses thereof
|
CA2338982C
(en)
|
1998-08-10 |
2011-03-15 |
Urogenesys, Inc. |
Bpc-1: a secreted brain specific protein expressed and secreted by prostate and bladder cancer cells
|
JP4723725B2
(ja)
|
1999-04-20 |
2011-07-13 |
ターゲット ディスカバリー, インコーポレイテッド |
代謝経路を分析するための方法
|
US6423503B1
(en)
*
|
1999-04-30 |
2002-07-23 |
Hybritech Incorporated |
Forms of free prostate-specific antigen (PSA) and their association with prostate tissues from prostate peripheral zone and transition zone
|
US6893818B1
(en)
*
|
1999-10-28 |
2005-05-17 |
Agensys, Inc. |
Gene upregulated in cancers of the prostate
|
FR2807438B1
(fr)
*
|
2000-04-10 |
2004-09-17 |
Bio Merieux |
Nouveaux anticorps reconnaissant specifiquement le psa libre inactif, et leurs applications
|
GB0012718D0
(en)
*
|
2000-05-24 |
2000-07-19 |
Angeletti P Ist Richerche Bio |
Conjugates of aminodrugs
|
FR2810114B1
(fr)
*
|
2000-06-13 |
2002-08-23 |
Bio Merieux |
Methode, procede, test immunologique et kit de diagnostic d'un adenocarcinome de la prostate ou d'une hypertrophie benigne de la prostate
|
ES2323407T3
(es)
|
2000-07-12 |
2009-07-15 |
Agensys, Inc. |
Nuevo antigeno tumoral util en el diagnostico y terapia del cancer de vejiga, ovario, pulmon y riñon.
|
US6379550B1
(en)
|
2000-07-24 |
2002-04-30 |
Health Research, Inc. |
Method for detecting PSA and its molecular forms using thiophilic gel
|
ATE282205T1
(de)
|
2000-07-24 |
2004-11-15 |
Health Research Inc |
Verfahren zur detektion von prostata-spezifischem membran-antigen in serum
|
US6984494B2
(en)
*
|
2000-08-15 |
2006-01-10 |
Genentech, Inc. |
Analytical method
|
CA2420543C
(en)
|
2000-08-22 |
2013-04-02 |
Agensys, Inc. |
Nucleic acid and corresponding protein named 158p1d7 useful in the treatment and detection of bladder and other cancers
|
CA2420990C
(en)
|
2000-08-28 |
2010-08-17 |
Agensys, Inc. |
Nucleic acid and corresponding protein entitled 85p1b3 useful in treatment and detection of cancer
|
US6764825B1
(en)
*
|
2000-10-13 |
2004-07-20 |
Tang J. Wang |
Methods and device for detecting prostate specific antigen (PSA)
|
US6924358B2
(en)
|
2001-03-05 |
2005-08-02 |
Agensys, Inc. |
121P1F1: a tissue specific protein highly expressed in various cancers
|
US7271240B2
(en)
|
2001-03-14 |
2007-09-18 |
Agensys, Inc. |
125P5C8: a tissue specific protein highly expressed in various cancers
|
US20030191073A1
(en)
|
2001-11-07 |
2003-10-09 |
Challita-Eid Pia M. |
Nucleic acid and corresponding protein entitled 161P2F10B useful in treatment and detection of cancer
|
WO2002083921A2
(en)
|
2001-04-10 |
2002-10-24 |
Agensys, Inc. |
Nuleic acids and corresponding proteins useful in the detection and treatment of various cancers
|
ES2537074T3
(es)
|
2001-09-06 |
2015-06-02 |
Agensys, Inc. |
Ácido nucleico y proteína correspondiente denominados STEAP-1 útiles en el tratamiento y la detección de cáncer
|
US7842498B2
(en)
|
2001-11-08 |
2010-11-30 |
Bio-Rad Laboratories, Inc. |
Hydrophobic surface chip
|
US7534580B2
(en)
*
|
2002-05-01 |
2009-05-19 |
Ambrilia Biopharma Inc. |
PSP94 diagnostic reagents and assays
|
WO2004016733A2
(en)
|
2002-08-16 |
2004-02-26 |
Agensys, Inc. |
Nucleic acid and corresponding protein entitled 251p5g2 useful in treatment and detection of cancer
|
US20040176577A1
(en)
*
|
2002-09-10 |
2004-09-09 |
Eva Rojer |
Immunoassays for specific determination of SCCA isoforms
|
EP1563100B1
(de)
*
|
2002-11-01 |
2013-04-24 |
Iris Molecular Diagnostics, Inc. |
Verdrängungs-sandwich-immuno-pcr
|
WO2004050828A2
(en)
|
2002-11-27 |
2004-06-17 |
Agensys, Inc. |
Nucleic acid corresponding protein entitled 24p4c12 useful in treatment and detection of cancer
|
WO2004072263A2
(en)
|
2003-02-10 |
2004-08-26 |
Agensys, Inc. |
Nucleic acid and corresponding protein named 158p1d7 useful in the treatment and detection of bladder and other cancers
|
WO2004094652A2
(en)
*
|
2003-04-22 |
2004-11-04 |
Neurobiotex, Inc. |
Zinc-based screening test and kit for early diagnosis of prostate cancer
|
NZ578591A
(en)
|
2003-05-30 |
2011-01-28 |
Agensys Inc |
Prostate stem cell antigen (PSCA) variants and subsequences thereof, namely SEQ ID NO: 6554
|
NZ551627A
(en)
|
2004-05-28 |
2010-02-26 |
Agensys Inc |
Antibodies and related molecules that bind to PSCA proteins
|
DE102004027429B4
(de)
|
2004-06-04 |
2018-09-13 |
Siemens Healthcare Diagnostics Gmbh |
Verfahren zur Anwendung von auf Markerwerten basierenden Dichtekarten bei der Diagnose von Patienten mit Krankheiten insbesondere von Tumoren
|
EP2302078B1
(de)
*
|
2004-11-03 |
2015-07-15 |
Iris Molecular Diagnostics, Inc. |
Mikrobläschen zur Konzentration mittels Affinitätstrennung
|
EP1842226B2
(de)
*
|
2004-11-03 |
2014-07-02 |
Iris International, Inc. |
Homogener nachweis von analyten
|
US8663600B2
(en)
*
|
2005-02-17 |
2014-03-04 |
Diaprost Ab |
Diagnosis of prostate cancer
|
US20080125582A1
(en)
*
|
2006-10-13 |
2008-05-29 |
Bio-Rad Laboratories, Inc. |
Methods and compositions for stabilizing prostate specific antigen
|
US20090088981A1
(en)
*
|
2007-04-26 |
2009-04-02 |
Neville Thomas B |
Methods And Systems Of Dynamic Screening Of Disease
|
ES2687620T3
(es)
|
2007-05-04 |
2018-10-26 |
Opko Diagnostics, Llc |
Dispositivo y método para análisis en sistemas microfluídicos
|
WO2009029550A2
(en)
*
|
2007-08-24 |
2009-03-05 |
Singulex, Inc. |
Highly sensitive system and methods for analysis of prostate specific antigen (psa)
|
US8362325B2
(en)
|
2007-10-03 |
2013-01-29 |
Ceres, Inc. |
Nucleotide sequences and corresponding polypeptides conferring modulated plant characteristics
|
CN103884840A
(zh)
*
|
2008-02-21 |
2014-06-25 |
艾瑞斯国际有限公司 |
早期确定前列腺癌治疗后复发的方法
|
WO2009148803A2
(en)
*
|
2008-05-15 |
2009-12-10 |
Soar Biodynamics, Ltd. |
Methods and systems for integrated health systems
|
WO2010075446A1
(en)
*
|
2008-12-23 |
2010-07-01 |
Soar Biodynamics, Ltd. |
Methods and systems for prostate health monitoring
|
US20100173791A1
(en)
|
2009-01-05 |
2010-07-08 |
Bio-Rad Laboratories, Inc. |
Process design using mass spectrometry
|
DE202010018623U1
(de)
|
2009-02-02 |
2018-12-07 |
Opko Diagnostics, Llc |
Strukturen zur Steuerung der Lichtwechselwirkung mit mikrofluidischen Vorrichtungen
|
EP2239675A1
(de)
|
2009-04-07 |
2010-10-13 |
BIOCRATES Life Sciences AG |
Verfahren zur In-vitro-Diagnose einer komplexen Krankheit
|
CN102346536A
(zh)
*
|
2010-07-29 |
2012-02-08 |
元太科技工业股份有限公司 |
省电触控电子书
|
CA2831398C
(en)
|
2011-03-28 |
2020-06-09 |
Sekisui Medical Co., Ltd. |
Psa assay and reagent therefor
|
US20140308204A1
(en)
|
2011-10-25 |
2014-10-16 |
Memorial Sloan Kettering Cancer Center |
Free psa antibodies as diagnostics, prognostics and therapeutics for prostate cancer
|
BR112014013853A2
(pt)
|
2011-12-09 |
2020-01-14 |
Ceres Inc |
uso de um ácido nucleico isolado, método de obtenção de uma célula vegetal transgênica, método de obtenção de uma planta transgênica, método de produção de uma planta, método de produção de biomassa, método de processamento de biomassa, método de alteração da composição de biomassa, método de modulação de composição de biomassa, método de produção de um produto de forragem
|
EP2823427B1
(de)
|
2012-03-05 |
2020-12-16 |
OY Arctic Partners AB |
Computersysteme, Verfahren und computerlesbares Speichermedium zur Vorhersage des Risikos des Prostatadrüsenvolumens
|
EA201691952A1
(ru)
|
2014-03-28 |
2017-05-31 |
Опкоу Дайагностикс, Ллк. |
Композиции и методы, имеющие отношение к диагностике рака предстательной железы
|
DK3253800T3
(da)
|
2015-03-27 |
2021-05-31 |
Opko Diagnostics Llc |
Prostata antigen standarder og bruge deraf
|
CN108802392A
(zh)
*
|
2018-08-29 |
2018-11-13 |
上海市东方医院 |
一种用于诊断前列腺癌的层析试纸条及其制备方法和应用
|